Olena Ivanova, Ludwig Maximilian University of Munich; Andrea Rachow, Ludwig Maximilian University of Munich; Denise Evans, University of the Witwatersrand, and Tembeka Sineke, University of the Witwatersrand
To understand the perceptions of TB patients about their quality of life, it’s useful to have a comparison with “apparently healthy” people.
New remedies are needed as rates of multi-drug resistant TB rise.
Jarun Ontakrai/Shutterstock
Helen Ayles, London School of Hygiene & Tropical Medicine
We expected to find that screening everybody for TB would identify individuals not yet diagnosed, and treating them quickly would reduce the prevalence of TB in the community.
Inhaled vaccine delivery could take on not only COVID-19, but also other respiratory infections, including tuberculosis.
(Shutterstock)
An inhaled COVID-19 vaccine would go directly to where the body would use it: the mucosal surface of the airways. This could mean less waste and more benefit, lower costs and reduced side-effects.
The mortality rate among young adults is higher than it should be, statistically.
Sammie Chaffin/Unsplash
The risk of dying changes over the course of a lifetime. Very high at birth, it falls and then gradually rises again… except for a peak after adolescence. Why such a statistical anomaly?
India’s recent Tuberculosis survey showed worse results than expected.
People receiving medical treatment at the entrance hall of Ayder Referral Hospital in Mekele, the capital of Tigray region, Ethiopia.
YASUYOSHI CHIBA/AFP via Getty Images
Unless special attention is given to conflict and HIV the war will undermine the achievement of the 2030 goals to end AIDS, discrimination, and new infections.
Head of the Immunology Research Group at the Division of Molecular Biology & Human Genetics, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Stellenbosch University
Infectious Diseases Physician and Senior Clinical Lecturer, Liverpool School of Tropical Medicine and Honorary Research Associate, University of Liverpool
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand